Apogee TherapeuticsAPGE
那斯達克 · USD
85.06
+2.34
(+2.82%)
盤中 06/11 10:32 (UTC+8)
06/11 10:32 (UTC+8)
Apogee TherapeuticsAPGE
85.06
+2.34
(+2.82%)
財務數據
損益表
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | |
營業收入淨額 | - | - | - | - | - | - | - | - | - | - |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | - | - | - | - | - | - | - | - | - | - |
營業費用 | 82,772 | 78,056 | 71,278 | 73,165 | - | - | - | - | - | 37,155 |
研發費用 | 60,819 | 58,444 | 54,178 | 55,703 | 46,387 | 60,229 | 45,714 | 33,206 | 28,716 | 28,954 |
推銷及管理費用 | 21,953 | 19,612 | 17,100 | 17,462 | 16,709 | 15,652 | 12,972 | 10,916 | 9,465 | 8,201 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -82,772 | -78,056 | -71,278 | -73,165 | -63,096 | -75,881 | -58,686 | -44,122 | -38,181 | -37,155 |
其他收入及費用 | 8,740 | 8,731 | 6,318 | 7,141 | 7,840 | 8,681 | 9,668 | 10,306 | 6,087 | 5,420 |
利息費用 | - | - | - | - | - | - | - | - | - | - |
稅前純益 | -74,032 | -69,325 | -64,960 | -66,024 | -55,256 | -67,200 | -49,018 | -33,816 | -32,094 | -31,735 |
所得稅 | 79 | 62 | 61 | 72 | 83 | 18 | - | - | - | - |
稅後純益 | -74,111 | -69,387 | -65,021 | -66,096 | -55,339 | -67,218 | -49,018 | -33,816 | -32,094 | -31,735 |
基本每股稅後盈餘(元) | -1.06 | -1.10 | -1.08 | -1.11 | -0.93 | -1.20 | -0.86 | -0.60 | -0.64 | - |
稀釋每股稅後盈餘(元) | -1.06 | -1.03 | -1.11 | -1.13 | -0.95 | -1.19 | -0.87 | -0.60 | -0.64 | -0.32 |
基本平均股數(千股) | 69668.00 | 63503.00 | 60147.00 | 59587.00 | 59526.00 | 57276.00 | 56795.00 | 56515.00 | 50189.00 | - |
稀釋平均股數(千股) | 69668.00 | 63503.00 | 60147.00 | 59587.00 | 59526.00 | 57276.00 | 56795.00 | 56515.00 | 50189.00 | - |
還原基本每股稅後盈餘(元) | -1.06 | -1.10 | -1.08 | -1.11 | -0.93 | -1.20 | -0.86 | -0.60 | -0.64 | - |
還原稀釋每股稅後盈餘(元) | -1.06 | -1.03 | -1.11 | -1.13 | -0.95 | -1.19 | -0.87 | -0.60 | -0.64 | -0.32 |
還原基本平均股數(千股) | 69,668 | 63,503 | 60,147 | 59,587 | 59,526 | 57,276 | 56,795 | 56,515 | 50,189 | - |
還原稀釋平均股數(千股) | 69,668 | 63,503 | 60,147 | 59,587 | 59,526 | 57,276 | 56,795 | 56,515 | 50,189 | - |
EBITDA(千元) | -75,173 | -70,661 | -66,174 | -67,385 | -57,428 | -70,110 | -52,475 | -36,820 | -34,775 | -34,574 |